Notícias

FTC Files Amicus Brief Outlining Anticompetitive Harm Caused by Improper Orange Book Listings

FTC Returns Additional $857,000 To Consumers Harmed by Napleton Auto’s Junk Fees and Discriminatory Practices

Commission carries out unannounced inspections in the online food delivery sector

Commission sends Adobe Statement of Objections over proposed acquisition of Figma

CMA sets out changes to Phase 2 merger processes

Casos

CADE

Atos de concentração aprovados

Ato de Concentração nº 08700.006524/2023-23. Requerentes: Porto Seguro Companhia de Seguros Gerais e Mitsui Sumitomo Seguros S.A. Advogados: Raquel M. S. Otranto Colangelo, Rogérgio Carmona Bianco, Diego Billi Falcão, Antonio Heraldo Wajnman Lima, Leonardo Rocha e Silva, Jackson Ferreira e Alexandre H. P. Oliveira. Decido pela aprovação sem restrições.

Comissão Europeia

CINVEN / SYNLAB

Merger

M.11300

Last Decision Date: 20.11.2023 Simplified procedure

AVIALLIANCE / AIA

Merger

M.11285

Last Decision Date: 20.11.2023 Super simplified procedure

CMA

• Theramex/European Rights to Viatris’ Femoston and Duphaston productsThe CMA is investigating the acquisition by Theramex HQ UK Limited of certain rights to Viatris Inc’s Femoston and Duphaston products.
  • Updated: 21 November 2023
• Reviews of three merger undertakings and one market investigation OrderThe CMA is reviewing three merger remedies and one market investigation Order.
  • Updated: 21 November 2023
• Consultation on reviews of three merger undertakings and one market investigation OrderThe CMA is seeking views from interested stakeholders for its reviews of three merger remedies and one market investigation Order.
  • Updated: 21 November 2023
• Consultation on new draft guidance on mergers: exceptions to the duty to referThe CMA is consulting on proposed updates to its published guidance relating to the application of the ‘de minimis’ exception.
  • Updated: 20 November 2023
• CMA sets out changes to Phase 2 merger processesThe CMA is planning to improve some aspects of its phase 2 processes as part of an evolution of how it investigates mergers.
  • Updated: 20 November 2023
• Call for information: Phase 2 merger investigationsThe Competition and Markets Authority (CMA) is inviting views on whether there are aspects of the Phase 2 merger process that could work better
  • Updated: 20 November 2023
• Phase 2 merger investigations: call for information and updates to guidance (CMA2)The Competition and Markets Authority’s (CMA) call for information on phase 2 merger investigations process, and related updates to CMA2 guidance.
  • Updated: 20 November 2023
• Sarah Cardell: the future of UK merger controlA keynote speech by Sarah Cardell, Chief Executive of the Competition and Markets Authority (CMA), to the CMA’s UK merger control event.
  • Updated: 20 November 2023
• Martin Coleman: UK merger control in the post-Brexit eraA speech by Martin Coleman, Non-Executive Director and Panel Chair of the Competition and Markets Authority (CMA), to the CMA’s UK merger control event.
  • Updated: 20 November 2023
• Changes to CMA mergers guidance (CMA2)The Competition and Markets Authority (CMA) is consulting on proposed updates to its published guidance on its merger investigation process.
  • Updated: 20 November 2023